role prostacyclin cardiovascular response thromboxane
thromboxane tx vasoconstrictor platelet agonist aspirin affords cardioprotection inhibition txa formation platelet cyclooxygenase cox- prostacyclin pgi vasodilator inhibits platelet function show injury-induced vascular proliferation platelet activation enhanced mice genetically deficient pgi receptor ip depressed mice genetically deficient txa receptor tp treated tp antagonist augmented response vascular injury abolished mice deficient receptors thus pgi modulates platelet-vascular interactions vivo specifically limits response txa interplay may help explain adverse cardiovascular effects associated selective cox inhibitors unlike aspirin nonsteroidal anti-inflammatory drugs nsaids inhibit pgi txa
